title: Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer.
authors.forename: Cheng-Jeng
authors.initials: CJ
authors.lastname: Tai
authors.forename: Chung-Huei
authors.initials: CH
authors.lastname: Hsu
authors.forename: Feng-Jeh
authors.initials: FJ
authors.lastname: Wang
authors.forename: Wing-Keung
authors.initials: WK
authors.lastname: Chau
authors.forename: Chi-Li
authors.initials: CL
authors.lastname: Chung
authors.forename: Chih-Cheng
authors.initials: CC
authors.lastname: Hsieh
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000601:surgery; D000068818:Cetuximab; D002945:Cisplatin / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D016879:Salvage Therapy / Q000379:methods; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003841:Deoxycytidine; D000068818:Cetuximab; D002945:Cisplatin; D000093542:Gemcitabine